Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance

Clinics (Sao Paulo). 2020 Apr 17;75:e1909. doi: 10.6061/clinics/2020/e1909. eCollection 2020.

Abstract

The world is fighting the COVID-19 outbreak and health workers, including inflammatory bowel diseases specialists, have been challenged to address the specific clinical issues of their patients. We hereby summarize the current literature in the management of inflammatory bowel disease (IBD) patients during the COVID-19 pandemic era that support the rearrangement of our IBD unit and the clinical advice provided to our patients.

Publication types

  • Review

MeSH terms

  • Adult
  • Betacoronavirus*
  • Brazil
  • Child
  • Coronavirus Infections / epidemiology*
  • Female
  • Humans
  • Inflammatory Bowel Diseases / epidemiology*
  • Inflammatory Bowel Diseases / therapy*
  • Male
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2